Patient Compliance: Clinical Trials

61 trials for Patient Compliance, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

39 completed, 11 unknown, 3 active not recruiting, 3 recruiting. 61 Phase 3, 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 361Completed 39, Unknown 11, Active not recruiting 3, Recruiting 3, Withdrawn 3, Terminated 2
Phase 29Completed 6, Withdrawn 2, Unknown 1

Follow Patient Compliance: new trials by email Literature Review of Patient Compliance trials Research Report on Patient Compliance

Trials (filtered) newest first · largest first

All 61 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Basal Cell Carcinoma Chemoprevention Trial
5% Imiquimod cream, Placebo Vehicle Control Cream - Basal Cell Carcinoma
Phase 3RecruitingVA Office of Research and Development16302026-10-062026-11-02
Evaluation of a Disability-Focused Sexual and Reproductive Health Curriculum for Health Students in Tanzania
Disability-Focused Sexual and Reproductive Health Curriculum - Sexual and Reproductive Health, Disability
Phase 3Active not recruitingUniversity of Minnesota4122026-09-012026-09-17
Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II)
Polycap - Stroke, Medication Adherence
Phase 3RecruitingNorthern California Institute of Research and Education10002026-04-012026-07-06
Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention
A-TEAM - HIV Infections, Adherence, Medication
Phase 3Active not recruitingUniversity of Illinois at Chicago1262024-10-012026-08-17
Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals
cabotegravir/rilpivirine (600mg/ 900mg), Antiretroviral Combinations - HIV-1-infection, Non-Adherence, Medication
Phase 3Active not recruitingChang Gung Memorial Hospital402024-07-192026-10-26
Identification of Surrogate Blood and/or Urine Biomarker for Immulina TM (Trademark) in Normal Humans
Immulina - Adherence, Patient
Phase 3CompletedUniversity of Mississippi Medical Center202023-08-092026-07-30
Next Generation Ingestible Sensors for Medication Adherence Measurement
Next-generation Reader and ID-Cap System, Truvada for pre-exposure prophylaxis (PrEP), Biktarvy for antiretroviral therapy (ART) - HIV Infection, Adherence, Medication
Phase 3CompletedBrigham and Women's Hospital152023-02-062024-09-25
SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder
Descovy or Truvada, ID-Cap System, Beiwe - HIV Infections, Substance Use
Phase 3CompletedBrigham and Women's Hospital402022-12-202026-07-21
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
Janus Kinase Inhibitor, Abatacept - Abatacept, Treatment Compliance
Phase 3UnknownZhejiang Provincial People's Hospital902022-09-302022-09-23
EFFICACY OF ANSA (Experimental Drug) & CRAN MAX (Control Drug) SACHET
to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli infection - Treatment Compliance
Phase 3UnknownShifa Ul Mulk Memorial Hospital1002021-08-122022-10-07
Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors
Motivational enhancement therapy, Attention Control - Breast Cancer, Medication Adherence
Phase 2 / Phase 3WithdrawnUniversity of Calgary2020-08-012024-12-05
Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY)
Customized Adherence Enhancement, Haloperidol Decanoate - Schizophrenia, Medication Nonadherence
Phase 3CompletedCase Western Reserve University222019-11-052021-10-12
Low Doses of Aspirin in the Prevention of Preeclampsia
acetylsalicylic acid - Preeclampsia
Phase 3CompletedWeill Medical College of Cornell University4002019-10-212025-03-13
Homeless Care Management App
In-Person Case Management at Homeless Recovery Program, Unlimited Smartphone, Smartphone Based Case Management (SPCM) app - Substance Use Disorders, Mental Health Impairment
Phase 3CompletedUniversity of Oklahoma4032018-04-272024-12-19
Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C]
Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a - Hepatitis C, Chronic
Phase 2 / Phase 3CompletedJohns Hopkins Bloomberg School of Public Health1502018-02-022021-05-18
SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients
Oxaliplatin, Tegafur,gimeracil and oteracil potassium, Xeloda - Colorectal Cancer Stage III, Adjuvant Chemotherapy
Phase 3UnknownPeking University Cancer Hospital & Institute11912018-01-012020-03-06
Incidence of Non Adherence to Treatment With Once-daily Formulation of Tacrolimus
Tacrolimus BID, Advagraf QD - Medication Adherence
Phase 3UnknownRabin Medical Center602016-08-012016-07-12
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
Cytoreductive prostatectomy or brachytherapy, ADT+second-generation antiandrogens ± chemotherapy - Metastatic Prostate Cancer, Therapy, Directly Observed
Phase 3RecruitingThe First Affiliated Hospital with Nanjing Medical University2002016-01-012024-04-05
Actual Use Trial of Ibuprofen 400 mg
Ibuprofen 400 mg caplet - Patient Compliance
Phase 3CompletedPfizer7382014-11-012016-05-30
SystemCHANGE: An Intervention for Medication Change in Adult Kidney Transplant Patients
SystemCHANGE, Patient-education attention control - Kidney Disease
Phase 3UnknownCynthia Russell842014-06-012018-05-04

Showing 20 of 61. Sign in to see all of them.

Narrower conditions

Medication Adherence (19)  ·  HIV Infections (6)  ·  Health Education (6)  ·  Diabetes Mellitus (4)  ·  Hypertension (4)  ·  Psychotic Disorders (4)  ·  Behavior (3)  ·  Directly Observed Therapy (3)  ·  Schizophrenia (3)  ·  Substance-Related Disorders (3)  ·  Treatment Adherence and Compliance (3)  ·  Colitis, Ulcerative (2)  ·  Colorectal Neoplasms (2)  ·  Hyperlipidemias (2)

Broader conditions

Health Behavior (60)  ·  Patient Acceptance of Health Care (60)  ·  Behavior (58)  ·  Treatment Adherence and Compliance (58)  ·  Immune System Diseases (11)  ·  Infections (11)  ·  Urogenital Diseases (11)  ·  Medication Adherence (10)  ·  Mental Disorders (10)  ·  Blood-Borne Infections (9)  ·  Communicable Diseases (9)  ·  Genital Diseases (9)  ·  Metabolic Diseases (9)  ·  Nutritional and Metabolic Diseases (9)

Interventions

Motivational Interviewing (3)  ·  Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (2)  ·  Tacrolimus (2)  ·  Abatacept (1)  ·  Alprazolam (1)  ·  Amyloid (1)  ·  Artemether, Lumefantrine Drug Combination (1)  ·  Aspirin (1)  ·  Atenolol (1)  ·  Brachytherapy (1)  ·  Capecitabine (1)  ·  Chlorhexidine (1)  ·  Cisplatin (1)  ·  Crisis Intervention (1)  ·  Dosage Forms (1)

Sponsors

Brigham and Women's Hospital (3)  ·  VA Office of Research and Development (3)  ·  University Health Network, Toronto (2)  ·  Yale University (2)  ·  ALK-Abelló A/S (1)  ·  Aga Khan University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  AstraZeneca (1)  ·  Case Western Reserve University (1)  ·  Centers for Disease Control and Prevention (1)  ·  Chang Gung Memorial Hospital (1)  ·  Chestnut Hill Health System (1)  ·  Cynthia Russell (1)  ·  Erasmus Medical Center (1)  ·  Federal University of Minas Gerais (1)

Countries

United States (28)  ·  Canada (6)  ·  China (3)  ·  Tanzania (3)  ·  Brazil (2)  ·  Germany (2)  ·  Pakistan (2)  ·  United Kingdom (2)  ·  Benin (1)  ·  Denmark (1)  ·  France (1)  ·  Ghana (1)  ·  India (1)  ·  Iran (1)  ·  Israel (1)

Top investigators

Carl J Stepnowsky, PhD (2)  ·  Abdul Jabbar, MBBS, FRCP (1)  ·  Ahmad Shavakhi, M.D. (1)  ·  Aiwen Wu, M.D. (1)  ·  Ali Khowaja, FRCS (1)  ·  Barbara C Tilley, PhD (1)  ·  Bilal Ahmed, MSc (1)  ·  Carl Latkin, PhD (1)  ·  Daniel H. Solomon, MD, MPH (1)  ·  David J Becker, MD (1)  ·  David William Sparrow, DSc (1)  ·  Delwyn Catley, Ph.D. (1)  ·  Eyan Mor, MD (1)  ·  Femida H Gwadry-Sridhar, PhD (1)  ·  Gailen D Marshall, Jr., MD, PhD (1)

Results publications

PMID 36094829, PMID 17441783, PMID 17513285, PMID 19122865, PMID 19300114, PMID 21663597, PMID 21666744, PMID 21840137, PMID 22131999, PMID 22192273, PMID 22371876, PMID 22713093, PMID 23362861, PMID 23816039, PMID 24671104, PMID 24977401, PMID 26051201, PMID 26135553, PMID 26711164, PMID 27081187, PMID 27421884, PMID 28360027, PMID 28440211, PMID 29065955, PMID 29871852, PMID 29895280, PMID 31291507, PMID 31466882, PMID 32438024, PMID 33293392, PMID 33870484, PMID 35086504, PMID 37932493, PMID 40243391, PMID 40633954, PMID 41296512, PMID 41727852

NIH funding

1RC1MH088341 (1), DP2DA056107 (1), P60AR047782 (1), R01AA018923 (1), R01CA133068 (1), R01DA026727 (1), R01DK064695 (1), R01HD110999 (1), R01MD010733 (1), R21MH114700 (1), R42AG021844 (1), U19AT010838 (1)